Role of beta-adrenergic receptor signaling and desensitization in heart failure: new concepts and prospects for treatment.

Published

Journal Article (Review)

The use of beta-blockers to antagonize beta-adrenergic receptor signaling in the heart has become a standard method of treatment for heart failure, resulting in positive clinical outcomes alone and in conjunction with other modulators of cardiomyocyte contractility. However, an entire explanation for improved cardiac function in patients using beta-blockers is unknown, and in fact may be quite complicated, considering the numerous intracellular signaling pathways associated with beta-adrenergic receptors. Stimulation of beta-adrenergic receptors during both normal conditions and during heart failure activate several distinct signaling cascades, which influence cardiomyocyte contraction, hypertrophy and apoptosis. This review explores the signaling cascades induced by beta-adrenergic receptor activation in normal and desensitized states to provide new insight into the effective treatment of cardiac dysfunction.

Full Text

Duke Authors

Cited Authors

  • Tilley, DG; Rockman, HA

Published Date

  • May 2006

Published In

Volume / Issue

  • 4 / 3

Start / End Page

  • 417 - 432

PubMed ID

  • 16716102

Pubmed Central ID

  • 16716102

Electronic International Standard Serial Number (EISSN)

  • 1744-8344

Digital Object Identifier (DOI)

  • 10.1586/14779072.4.3.417

Language

  • eng

Conference Location

  • England